Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
819 Capital Partners is a venture capital firm founded in 2021 and based in the Netherlands. The firm specializes in venture capital, private equity, and corporate finance, focusing on driving innovation, growth, and value creation through a diverse portfolio of investments. Since its inception, 819 Capital Partners has established itself as a key player in the European investment landscape, particularly in the Netherlands.
The firm currently manages a portfolio of nine companies and operates through various funds, including the 819 Evergreen Fund, which emphasizes investments in deep-tech ventures that address societal challenges. The firm’s commitment to innovation is reflected in its active acquisition strategy, which includes recent investments in companies like Lead Pharma and Chalet.nl.
819 Capital Partners is strategically located in Deventer and Amsterdam, allowing it to tap into the vibrant Dutch startup ecosystem. The firm’s LP base includes a mix of institutional investors and high-net-worth individuals, providing a solid foundation for its investment activities.
819 Capital Partners invests across multiple sectors, with a strong emphasis on healthcare and frontier technologies. The firm targets various stages of investment, including pre-seed, seed, seed-plus, Series A, and Series B. This broad investment strategy allows them to support startups at different growth phases, from early-stage ventures to more established companies.
The firm’s investment strategy is particularly focused on deep-tech ventures that address significant societal challenges. Through the 819 Evergreen Fund, they seek to identify and support innovative companies that leverage advanced technologies to create impactful solutions. 819 Capital Partners values founders who demonstrate a clear vision and the ability to execute their ideas effectively.
819 Capital Partners has a diverse portfolio of nine companies, showcasing its commitment to innovation across various sectors. Notable portfolio companies include:
This portfolio reflects the firm’s focus on healthcare and technology, with companies that are positioned to make significant impacts in their respective fields.
Wim Smit: Partner, Co-founder. Wim has extensive experience in venture capital and private equity, having previously worked at several notable firms. He specializes in healthcare investments and has led multiple successful funding rounds.
Sven Kempers: Partner, Co-founder. Sven brings a strong background in corporate finance and has been instrumental in developing the firm’s investment strategy. He focuses on technology and deep-tech sectors.
Thomas Smit: Partner, Co-founder. Thomas has a rich history in entrepreneurship and venture capital, with expertise in scaling startups. He plays a key role in mentoring portfolio companies.
Gijs Berkenbosch: Investment Associate. Gijs supports the investment team in deal sourcing and due diligence, with a keen interest in emerging technologies.
Joris Bokkes: Venture Partner. Joris has a background in technology and innovation, providing valuable insights into the firm’s investment decisions.
To pitch 819 Capital Partners, founders should send an email to info@819-capital.com. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, competitive landscape, and team qualifications. The firm appreciates clarity and conciseness in presentations.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
In recent months, 819 Capital Partners has been active in expanding its portfolio. Notable acquisitions include key stakes in Lead Pharma and Chalet.nl, as well as a significant minority stake in RiverD. These investments reflect the firm’s commitment to supporting innovation in healthcare and technology sectors.
Additionally, the firm continues to explore new opportunities within the deep-tech space, aligning with its investment thesis focused on addressing societal challenges through advanced technologies.
What are the investment criteria for 819 Capital Partners?
819 Capital Partners invests in early-stage ventures to established companies across various sectors, particularly healthcare and deep-tech. They look for innovative solutions that address societal challenges.
How can I pitch to 819 Capital Partners?
Founders can pitch by sending an email to info@819-capital.com. It is advisable to include a detailed deck outlining the business model, market opportunity, and team background.
What makes 819 Capital Partners different from other VCs?
The firm emphasizes deep-tech investments that tackle societal challenges, setting it apart from many other venture capital firms that may focus on broader technology sectors.
What is the geographic focus of 819 Capital Partners?
819 Capital Partners primarily focuses on investments within Europe, with a strong presence in the Netherlands.
What is the typical check size for investments?
While specific check sizes are not disclosed, the firm invests across various stages, including pre-seed, seed, and Series A, indicating a flexible approach to funding amounts based on the stage of the company.
What kind of post-investment support does 819 Capital Partners provide?
The firm actively engages with its portfolio companies, providing strategic guidance and resources to help them grow and succeed in their respective markets.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.